Antibody‐Mediated Mechanisms in Autoimmune Neurological Disorders
European Journal of Neuroscience · 2026-07 · 64 (2)
DOI: 10.1111/ejn.70642 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, online erschienen am 28.07.2026. Verfasst von Estibaliz Maudes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Centre, Göttingen, Germany. Hauptthemen laut MEDLINE: Autoantibodies, Encephalitis, Autoimmune Diseases of the Nervous System, Hashimoto Disease. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Committee for Treatment and Research in Multiple Sclerosis, Spanish National Health Institute Carlos III Spain, Commission for Cultural, Educational and Scientific Exchange.
Abstract (Originalsprache)
Antibody‐mediated encephalitides are a rapidly evolving class of disorders in which autoantibodies against neuronal surface proteins disrupt synaptic function, neural circuits and cognition. This article summarizes the presentations and discussions from a symposium at the 2025 meeting of the Spanish Society of Neuroscience (SENC). Rather than providing a comprehensive review of autoimmune encephalitis, we highlight selected advances that illustrate how antibody‐mediated mechanisms contribute to neurological dysfunction, using anti‐NMDAR encephalitis as a paradigmatic example. Specifically, we contrast experimental approaches that have shaped current understanding of disease pathogenesis, including in vitro systems, passive‐transfer mouse models and active immunization paradigms that capture B‐cell responses, intrathecal immunity, microglial engagement and relapse biology. We also examine emerging evidence that antibody Fc features, including subclass and glycosylation, contribute to innate immune activation and clinical heterogeneity, with examples linking proinflammatory Fc signatures to poorer outcomes. Finally, we review selected studies addressing behavioural and cognitive consequences in animal models and patients, particularly long‐lasting deficits in working memory, and discuss therapeutic implications ranging from synapse‐stabilizing strategies and NMDAR positive allosteric modulators to B‐cell‐targeting treatments and approaches aimed at modulating Fc‐dependent pathways. Together, these findings suggest that integrating molecular immunoprofiling with systems neuroscience may improve prognostic accuracy and inform therapies that restore immune homeostasis and functional circuit recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Medical Centre, Göttingen, Germany.
- Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.
- CaixaResearch Institute, Barcelona, Spain.
- Institut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, Barcelona, Spain.
- Centro de Investigación Biomédica en Red, Enfermedades Raras (CIBERER), Madrid, Spain.
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Estibaliz Maudes
Förderung
- European Committee for Treatment and Research in Multiple Sclerosis
- Spanish National Health Institute Carlos III Spain
- Commission for Cultural, Educational and Scientific Exchange
Zitieren
APA
Maudes, E., Marmolejo, L., Serafim, A. B., Spatola, M., Compte, A., & Dalmau, J. (2026). Antibody‐Mediated Mechanisms in Autoimmune Neurological Disorders. European Journal of Neuroscience, 64(2). https://doi.org/10.1111/ejn.70642
Vancouver
Maudes E, Marmolejo L, Serafim AB, Spatola M, Compte A, Dalmau J. Antibody‐Mediated Mechanisms in Autoimmune Neurological Disorders. European Journal of Neuroscience. 2026;64(2). doi:10.1111/ejn.70642
BibTeX
@article{Maudes2026,
author = {Maudes, Estibaliz and Marmolejo, Laura and Serafim, Ana Beatriz and Spatola, Marianna and Compte, Albert and Dalmau, Josep},
title = {Antibody‐Mediated Mechanisms in Autoimmune Neurological Disorders},
journal = {European Journal of Neuroscience},
year = {2026},
volume = {64},
number = {2},
doi = {10.1111/ejn.70642}
}
EUVIMED